These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa. Liao Y, Ivanova L, Zhu H, Yahr A, Ayello J, van de Ven C, Rashad A, Uitto J, Christiano AM, Cairo MS. Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200 [Abstract] [Full Text] [Related]
3. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa. Liao Y, Itoh M, Yang A, Zhu H, Roberts S, Highet AM, Latshaw S, Mitchell K, van de Ven C, Christiano A, Cairo MS. Cell Transplant; 2014 Mar; 23(3):303-17. PubMed ID: 23394106 [Abstract] [Full Text] [Related]
10. Injury-Driven Stiffening of the Dermis Expedites Skin Carcinoma Progression. Mittapalli VR, Madl J, Löffek S, Kiritsi D, Kern JS, Römer W, Nyström A, Bruckner-Tuderman L. Cancer Res; 2016 Feb 15; 76(4):940-51. PubMed ID: 26676755 [Abstract] [Full Text] [Related]
11. Thrombospondin-1 Is a Major Activator of TGF-β Signaling in Recessive Dystrophic Epidermolysis Bullosa Fibroblasts. Atanasova VS, Russell RJ, Webster TG, Cao Q, Agarwal P, Lim YZ, Krishnan S, Fuentes I, Guttmann-Gruber C, McGrath JA, Salas-Alanis JC, Fertala A, South AP. J Invest Dermatol; 2019 Jul 15; 139(7):1497-1505.e5. PubMed ID: 30684555 [Abstract] [Full Text] [Related]
12. Decorin counteracts disease progression in mice with recessive dystrophic epidermolysis bullosa. Cianfarani F, De Domenico E, Nyström A, Mastroeni S, Abeni D, Baldini E, Ulisse S, Uva P, Bruckner-Tuderman L, Zambruno G, Castiglia D, Odorisio T. Matrix Biol; 2019 Aug 15; 81():3-16. PubMed ID: 30528862 [Abstract] [Full Text] [Related]